VIR - Vir Biotechnology to shed 12% of workforce as part of corporate restructuring
2023-12-13 17:41:15 ET
More on Vir Biotechnology
- Vir Biotechnology: A Relentless Slide In The Stock, Unresponsive To Positive Developments
- Vir Biotechnology, Inc. (VIR) Q3 2023 Earnings Call Transcript
- Vir Biotechnology: A Beaten Up Biotech With A Large Margin Of Safety
- Vir Biotechnology GAAP EPS of -$1.22 beats by $0.03, revenue of $2.6M misses by $6.17M
- Vir Biotechnology Q3 2023 Earnings Preview
For further details see:
Vir Biotechnology to shed 12% of workforce as part of corporate restructuring